PIN/LC8 is associated with cytosolic but not membrane-bound nNOS in the nitrergic varicosities of mice gut: implications for nitrergic neurotransmission.
This investigation demonstrates the presence and binding of the protein LC8 (described as "protein inhibitor of nNOS" or PIN in some reports) to different components of neuronal nitric oxide synthase (nNOS) in nitrergic varicosities of mice gut. Whole varicosity extracts showed three (320-, 250-, and 155-kDa) nNOS bands with anti-nNOS(1422-1433) antibody and a 10-kDa band with anti-LC8 antibody. The LC8 immunoprecipitate (IP) showed three nNOS bands, suggesting that LC8 was bound with all three forms of nNOS but dissociated from them during SDS-PAGE. Studies using LC8 IP and supernatant and probed with anti-CaM showed that LC8 was not associated with CaM-bound 320-kDa nNOS but was present in the CaM-lacking fraction. Probing these fractions with anti-serine847-P-nNOS showed that 320-kDa serine847-phosphorylated-nNOS consisted of LC8-bound and LC8-lacking components. Subsequent studies with varicosity membrane and cytosolic fractions separately showed that membrane contained CaM-bound and CaM-lacking, serine847-phosphorylated 320-kDa nNOS; both these fractions lacked LC8. On the other hand, the cytosolic fraction contained CaM-lacking, serine847-phosphorylated 320-kDa, 250-kDa, and 155-kDa nNOS bands that were all associated with LC8. These studies, along with in vitro nitric oxide assays, show that in gut nitrergic nerve varicosities 1) all cytosolic serine847-phosphorylated nNOS was catalytically inactive and bound with LC8, and 2) membrane-associated nNOS consisted of catalytically active, CaM-bound and catalytically inactive, CaM-lacking, serine847-phosphorylated nNOSalpha dimers, both of which lacked LC8. These results suggest that LC8 may dissociate from the 320-kDa nNOSalpha dimer upon binding to membrane, thus supporting the view that LC8 may transport nNOSalpha dimer to the varicosity membrane for participation in nitrergic neurotransmission.
Chaudhury
Arun
A
Center for Swallowing and Motility Disorders, Veterans Affairs Boston Healthcare System and Harvard Medical Center, Boston, MA, USA.
Rao
Y Manjula
YM
Goyal
Raj K
RK
D000818:Animals; D002147:Calmodulin / Q000378:metabolism; D002462:Cell Membrane / Q000201:enzymology*; D003600:Cytosol / Q000201:enzymology*; D004398:Dyneins / Q000378:metabolism*; D017615:Enteric Nervous System; D041981:Gastrointestinal Tract / Q000294:innervation*; D066298:In Vitro Techniques; D007527:Isoenzymes; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D026602:Nitrergic Neurons / Q000201:enzymology*; D009569:Nitric Oxide / Q000378:metabolism*; D052248:Nitric Oxide Synthase Type I / Q000378:metabolism*; D010766:Phosphorylation; D017729:Presynaptic Terminals / Q000201:enzymology; D011485:Protein Binding; D012694:Serine; D013347:Subcellular Fractions / Q000201:enzymology; D009435:Synaptic Transmission
D002147:Calmodulin; D007527:Isoenzymes; D009569:Nitric Oxide; D012694:Serine; D052248:Nitric Oxide Synthase Type I; C496321:Nos1 protein, mouse; D004398:Dyneins